Medicamen Biotech Ltd. - Research Center
531146 MEDICAMEQ Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
45.01 |
44.20 |
42.67 |
40.50 |
37.15 |
Operating profit |
6.82 |
5.58 |
6.15 |
7.41 |
6.77 |
Interest |
1.87 |
0.65 |
0.91 |
0.96 |
0.86 |
Gross profit |
5.50 |
5.77 |
5.80 |
6.83 |
6.26 |
EPS (Rs) |
2.44 |
2.19 |
2.38 |
3.49 |
3.20 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
0.54 |
0.83 |
0.55 |
0.38 |
0.35 |
Stock adjustment |
0.56 |
-4.11 |
-4.52 |
-5.24 |
-1.10 |
Raw material |
22.65 |
28.72 |
27.51 |
25.82 |
22.48 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
5.88 |
5.77 |
5.23 |
5.25 |
4.38 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
9.10 |
8.24 |
8.30 |
7.27 |
4.62 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.77 |
1.76 |
1.80 |
1.68 |
1.61 |
Taxation |
0.62 |
1.24 |
0.99 |
0.74 |
0.60 |
Net profit / loss |
3.10 |
2.77 |
3.01 |
4.42 |
4.05 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
12.71 |
12.65 |
12.65 |
12.65 |
12.65 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
15.16 |
12.63 |
14.42 |
18.30 |
18.22 |
GPM (%) |
12.07 |
12.81 |
13.41 |
16.71 |
16.69 |
NPM (%) |
6.81 |
6.14 |
6.97 |
10.80 |
10.79 |